Correction to: J Inflamm 7, 33 (2010)

https://doi.org/10.1186/1476-9255-7-33

Following publication of the original article [1], an error was reported in Fig. 1 and Fig. 4.

Figure 1 correction: The incorrect immunoblot panel was included in the original submission.

The correct immunoblot panel is included in the corrected Fig. 1 below.

Figure 4 correction: The incorrect PI3KδD910A/A910A immunoblot panel was included in the original submission. The correct immunoblot panel is included in the corrected Fig. 4 below.

The authors apologize unreservedly for this oversight during the original formatting of the manuscript.

Fig. 1
figure 1

Cigarette smoke exposure reduces lung mSin3a expression which is protected by glucocorticoid treatment. Budesonide treatment protected the lung expression of mSin3a in smoke exposed animals. Data represents the mean ± S.E.M (n = 7–8). *** p > 0.001 compared to air exposed sham. Abbreviations; Smoke: Smoke Exposed; Bud: Budesonide

Full size image
Fig. 4
figure 2

Abolition of PI3Kγ and δ signalling enables budesonide to protect lung Mi-2α expression after cigarette smoke exposure. Mi-2α expression levels in the lung were protected by budesonide treatment in both the PI3KδD910A/D910A mice and the PI3Kγ−/−mice but not the WT mice. Data represents the mean ± S.E.M (n = 7–8). *** p > 0.001 compared to air exposed sham. Abbreviations; Smoke: Smoke Exposed; Bud: Budesonide

Full size image